Myocardial flow reserve plays a significant role as a predictor of cardiac death in patients with diabetes.
Read More »21-Year Follow-up of STENO-2: Reducing Strokes and Increasing Life Expectancy — ADA 2019
The results of the STENO-2 study assessing the benefit of intensified therapy on risk of stroke.
Read More »CREDENCE Trial Shows Renal and Cardiovascular Protection
Strong results motivate the ADA to update its Standard of Care for patients with diabetes.
Read More »Cardiovascular Benefits of Intensive Antihypertensive Treatment in Patients with Diabetes
Specific antihypertensive treatment goals in high-risk patients are a widely controversial topic; which type of patient with diabetes benefits most from blood pressure lowering medications?
Read More »New Approval for Praluent (alirocumab): Prevention of Cardiovascular Outcomes
Expansion of the original 2015 approval makes Praluent a strong lipid-lowering candidate for patients with diabetes and other cardiovascular concerns.
Read More »Death Rates Increasing for Younger Adults Due to Heart Disease
The face of heart disease is changing in the U.S., and obesity and diabetes may be key factors.
Read More »Blood Pressure or Glucose: Which to Treat More Aggressively?
Is one more important than the other?
Read More »Not Only SGLT-2 Inhibitors to Prevent CVD
Another medication taken for type 2 diabetes may also help reverse a potentially life-threatening heart condition.
Read More »Nuts, CVD and Diabetes: Updated
To date, there is limited evidence concerning the potential health benefits of eating nuts for persons with T2D.
Read More »Instantaneous Outcomes of Simple Daily Walking on Arterial Stiffness for Type 2 Patients
Could the most inexpensive treatment for arterial stiffness be a healthy walk?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.